While these studies provide the first indications regarding important dysregulated pathways in CTEPH (e.g., TGF-β and PI3K signaling), additional in-depth investigations are required to fully understand the complex processes leading to CTEPH. This evidence concerns the gene TGFB1 and chronic thromboembolic pulmonary hypertension.